Last edition
News about "Taisho Pharmaceutical "
Kaigene Licenses Autoimmune Drug KG006 to Taisho Pharma in Japan
Taisho Pharmaceutical secures exclusive rights to clinically develop, register, and commercialise Kaigene's next-generation FcRn inhibitor, KG006, in Japan.
Taisho Pharmaceutical | 01/08/2026 | By News Bureau | 113
Biocytogen Grants Licence for RenNano Platform to Taisho Pharmaceutical
Biocytogen licenses its RenNano platform to Taisho Pharmaceutical to advance fully human heavy chain-only antibody discovery, supporting in-vivo screening and downstream research.
Taisho Pharmaceutical | 31/03/2026 | By News Bureau | 166
Evotec OAI Partners with Taisho Pharmaceutical to Accelerate Drug Discovery
Evotec OAI has entered into a drug discovery collaboration with Taisho Pharmaceutical Co., Ltd. Tokyo, Japan.
Taisho Pharmaceutical | 25/04/2024 | By Aishwarya | 578
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy